相关实验视频

Updated: Jul 17, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

综合性PANoptosis基因分析揭示了前列腺癌的预后和治疗见解

Yi Wang¹, Yiheng Du², Xizhi Wang²

¹Department of Urology, The First Affiliated Hospital of Soochow University, Suzhou, China; Department of Urology, Suzhou Kowloon Hospital, Shanghai Jiao Tong University School of Medicine, Suzhou, China.

Biomolecules & biomedicine

|June 19, 2025

概括

这项研究确定了与编程细胞死亡 (PANoptosis) 相关的四个基因特征,该特征可以预测前列腺癌 (PCa) 患者的生存率. 这一发现可以指导个性化免疫治疗策略,以更好地管理PCa.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
免疫学免疫学免疫学

背景情况:

前列腺癌 (PCa) 是男性癌症死亡的主要原因,治疗选择有限.
编程细胞死亡途径,特别是PANoptosis (整合性热,光和死),正在成为癌症治疗中的关键标.

研究的目的:

为了研究PANoptosis相关基因在前列腺癌中的作用.
根据PANoptosis基因表达,确定PCa的预后生物标志物.
探索 PANoptosis 与瘤微环境和免疫疗法反应的关联.

主要方法:

根据45个与PANoptosis相关的基因,将PCa患者分为PANoptosis高和PANoptosis低的子组.
进行了差异性基因表达和丰富分析.
开发并验证了四个基因风险特征 (CASP7,ADAR,DNM1L,NAIP) 的整体存活率 (OS).

主要成果:

确定了四个重要的基因特征 (CASP7,ADAR,DNM1L,NAIP),可以预测PCa中的OS.
签名证明了OS的独立预后价值.
发现了签名和瘤微环境因素之间的相关性,包括免疫细胞透和免疫治疗反应.

结论:

确定了与PANoptosis相关的基因特征,可以作为前列腺癌的潜在预后生物标志物.
这种签名可以为PCa患者开发个性化免疫治疗策略提供信息.
对PANoptosis途径的进一步研究可以提高PCa治疗结果.

更多相关视频

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

相关概念视频

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...